Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.3M Sell
203,034
-55,692
-22% -$6.54M 0.34% 29
2025
Q4
$32.3M Sell
258,726
-19,772
-7% -$2.36M 0.6% 23
2025
Q3
$33.4M Sell
278,498
-10,931
-4% -$1.15M 0.64% 24
2025
Q2
$26.6M Sell
289,429
-35,136
-11% -$3.2M 0.62% 23
2025
Q1
$28.6M Sell
324,565
-157,503
-33% -$15.5M 0.71% 17
2024
Q4
$44.6M Sell
482,068
-412,679
-46% -$39.7M 1.06% 10
2024
Q3
$83M Sell
894,747
-68,418
-7% -$5.75M 1.94% 8
2024
Q2
$72.2M Buy
963,165
+41,305
+4% +$3.3M 1.76% 8
2024
Q1
$79.5M Sell
921,860
-90,575
-9% -$6.92M 2% 7
2023
Q4
$70M Buy
1,012,435
+28,130
+3% +$1.7M 2.23% 9
2023
Q3
$53.9M Buy
+984,305
New +$55.9M 1.84% 9

Other funds holding CRH

Barings's CRH Position: Q1 2026 in Review

Barings reduced its CRH (CRH) stake by 22% in Q1 2026, selling an estimated $6.54M and leaving 203,034 shares worth $21.3M. The position accounts for 0.34% of the portfolio, ranked #29.

Barings first reported a position in CRH in Q3 2023 and has held it in 11 quarters since. The position peaked at $83M in Q3 2024. 1,006 funds tracked by Wall St. Rank hold CRH as of Q1 2026.

  • Barings held 203,034 shares of CRH worth $21.3M as of Q1 2026.
  • Barings sold 55,692 CRH shares in Q1 2026, an estimated $6.54M.
  • CRH made up 0.34% of Barings's portfolio in Q1 2026, its #29 holding.
  • Barings first reported a position in CRH in Q3 2023 and has held it in 11 quarters since.
  • Barings's CRH position peaked at $83M in Q3 2024.
  • 1,006 funds tracked by Wall St. Rank held CRH as of Q1 2026.

Based on Barings's 13F filing for Q1 2026, filed 6 May 2026.